| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate |
2001-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97d07faeeb341143f3e76bb5c7fafb96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dad2d179784fe9ce049dc4b08bddca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd6af5e4d83b64dbba218967230b7cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5b3f415b2f7176d88dc16162f5ebd2 |
| publicationDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BG-106193-A |
| titleOfInvention |
USE OF ANTIBODIES AGAINST CD20 FOR TREATMENT OF DISORDERS IN TRANSPLANTATIONS |
| abstract |
The invention relates to the use of antibodies against exogenous surface antigens that do not occur on normal human T-lymphocytes, the preparation of preparations for the treatment of host transplant rejection diseases in patients who have received T-lymphocytes transformed with such exogenous surface antigens . The invention relates to vectors for transfection of human T-lymphocytes with exogenous surface antigens and human T-lymphocytes transformed with exogenous surface antigens. |
| priorityDate |
1999-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |